Literature DB >> 8132830

Complement activation by cellulosic dialysis membranes.

A Innes1, A M Farrell, R P Burden, A G Morgan, R J Powell.   

Abstract

AIMS: To assess the effect of cellulosic dialysis membranes on the production of complement degradation products to determine to the role of the classical pathway.
METHOD: Complement activation was studied in 33 patients during a single haemodialysis session using cellulosic membranes. Pre- and post-dialysis plasma EDTA valves of C3, C4, C3dg, C4d and C reactive protein (CRP) were measured. Statistical analysis was done using the Wilcoxon signed rank test.
RESULTS: Post-dialysis C4 (p = 0.0003), C3dg (p < 0.0001), and C4d (p = 0.003) concentrations were increased compared with pre-dialysis values. There was no significant change in C3 (p = 0.095) and CRP (p = 0.13) values. Post-dialysis C3dg and C4d concentrations correlated significantly (p = 0.007). IgG, an undialysed molecule, was quantified and post-dialysis valves were significantly higher than those before dialysis (p = 0.0002), indicating a degree of haemoconcentration. To remove this effect, the C3:IgG, C4:IgG, C3dg:IgG, C4d:IgG and CRP:IgG ratios were calculated. Compared with pre-dialysis values, post-dialysis C3dg:IgG and C4d:IgG ratios were increased and C3:IgG decreased significantly. No change was observed in C4:IgG and CRP:IgG ratios.
CONCLUSION: This study confirms that significant complement activation takes place following dialysis with cellulosic membranes. This is denoted by an increase in C3dg. This was paralleled by a rise in C4d, implying a contributory role for the classical pathway. Concomitant post-dialysis increases in IgG and C4 indicate a degree of haemoconcentration; but removal of this effect shows that C3dg and C4d are increased following dialysis--suggesting classical, in addition to alternative, pathway activation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8132830      PMCID: PMC501832          DOI: 10.1136/jcp.47.2.155

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  12 in total

1.  Analysis of the complement C3 fragments associated with hemodialysis membranes.

Authors:  A K Cheung; C J Parker; J Janatova
Journal:  Kidney Int       Date:  1989-02       Impact factor: 10.612

Review 2.  The immunopathology of joint inflammation in rheumatoid arthritis.

Authors:  N J Zvaifler
Journal:  Adv Immunol       Date:  1973       Impact factor: 3.543

3.  Changes in pulmonary vascular tone during early hemodialysis.

Authors:  F Walker; R Lindsay; W Sibbald; A Linton
Journal:  Trans Am Soc Artif Intern Organs       Date:  1984

4.  Anaphylatoxin formation during hemodialysis: effects of different dialyzer membranes.

Authors:  D E Chenoweth; A K Cheung; L W Henderson
Journal:  Kidney Int       Date:  1983-12       Impact factor: 10.612

5.  Clinical application of new technique that measures C4d for assessment of activation of classical complement pathway.

Authors:  E T Davies; B A Nasaruddin; A Alhaq; G Senaldi; D Vergani
Journal:  J Clin Pathol       Date:  1988-02       Impact factor: 3.411

6.  Metabolic studies of the third component of complement and the glycine-rich beta glycoprotein in patients with hypocomplementemia.

Authors:  J A Charlesworth; D G Williams; E Sherington; P J Lachmann; D K Peters
Journal:  J Clin Invest       Date:  1974-06       Impact factor: 14.808

7.  Complement activation and hypersensitivity reactions to dialysis membranes.

Authors:  R M Hakim; J Breillatt; J M Lazarus; F K Port
Journal:  N Engl J Med       Date:  1984-10-04       Impact factor: 91.245

8.  Complement and leukocyte-mediated pulmonary dysfunction in hemodialysis.

Authors:  P R Craddock; J Fehr; K L Brigham; R S Kronenberg; H S Jacob
Journal:  N Engl J Med       Date:  1977-04-07       Impact factor: 91.245

9.  Activation of classical pathway complement in chronic inflammation. Elevated levels of circulating C3d and C4d split products in rheumatoid arthritis and Crohn's disease.

Authors:  N E Petersen; J Elmgreen; B Teisner; S E Svehag
Journal:  Acta Med Scand       Date:  1988

10.  Hemodialysis leukopenia. Pulmonary vascular leukostasis resulting from complement activation by dialyzer cellophane membranes.

Authors:  P R Craddock; J Fehr; A P Dalmasso; K L Brighan; H S Jacob
Journal:  J Clin Invest       Date:  1977-05       Impact factor: 14.808

View more
  4 in total

Review 1.  The Complement System in Dialysis: A Forgotten Story?

Authors:  Felix Poppelaars; Bernardo Faria; Mariana Gaya da Costa; Casper F M Franssen; Willem J van Son; Stefan P Berger; Mohamed R Daha; Marc A Seelen
Journal:  Front Immunol       Date:  2018-01-25       Impact factor: 7.561

Review 2.  Immunological Effects of a Single Hemodialysis Treatment.

Authors:  Andrea Angeletti; Fulvia Zappulo; Chiara Donadei; Maria Cappuccilli; Giulia Di Certo; Diletta Conte; Giorgia Comai; Gabriele Donati; Gaetano La Manna
Journal:  Medicina (Kaunas)       Date:  2020-02-12       Impact factor: 2.430

3.  Ribociclib Nanostructured Lipid Carrier Aimed for Breast Cancer: Formulation Optimization, Attenuating In Vitro Specification, and In Vivo Scrutinization.

Authors:  Ali Sartaj; Largee Biswas; Anita Kamra Verma; P K Sahoo; Sanjula Baboota; Javed Ali
Journal:  Biomed Res Int       Date:  2022-02-03       Impact factor: 3.411

4.  Intradialytic Complement Activation Precedes the Development of Cardiovascular Events in Hemodialysis Patients.

Authors:  Felix Poppelaars; Mariana Gaya da Costa; Bernardo Faria; Stefan P Berger; Solmaz Assa; Mohamed R Daha; José Osmar Medina Pestana; Willem J van Son; Casper F M Franssen; Marc A Seelen
Journal:  Front Immunol       Date:  2018-09-13       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.